Order Article Reprints

Jiang Y, Huang C, Huang Y, Long L, Wu G, Guo F, Huang C, Liu S, Zhu Z, Wu S, et al. A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma. Pharmaceutics. 2023; 15(5):1501. https://doi.org/10.3390/pharmaceutics15051501

Jiang, Ying, Chunhui Huang, Yaqi Huang, Lifan Long, Guowu Wu, Fengqiu Guo, Chuan Huang, Siming Liu, Zhengguang Zhu, Shaoyu Wu, and et al. 2023. "A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma" Pharmaceutics 15, no. 5: 1501. https://doi.org/10.3390/pharmaceutics15051501

Jiang, Y., Huang, C., Huang, Y., Long, L., Wu, G., Guo, F., Huang, C., Liu, S., Zhu, Z., Wu, S., Li, Z., Zhang, J., & Wan, S. (2023). A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma. Pharmaceutics, 15(5), 1501. https://doi.org/10.3390/pharmaceutics15051501